KEGG: sah:SaurJH1_2001
The recombinant UPF0316 protein SaurJH1_2001 requires specific storage conditions to maintain stability and functionality:
| Parameter | Recommended Condition | Notes |
|---|---|---|
| Long-term storage | -20°C or -80°C | Aliquoting necessary for multiple use |
| Working storage | 4°C | For up to one week |
| Buffer composition | Tris/PBS-based buffer with 6% Trehalose, pH 8.0 | Optimized for stability |
| Physical form | Lyophilized powder | For long-term stability |
| Reconstitution | Deionized sterile water (0.1-1.0 mg/mL) | Add 5-50% glycerol for long-term storage |
| Important caution | Avoid repeated freeze-thaw cycles | Causes protein degradation |
Repeated freezing and thawing significantly reduces protein stability and should be strictly avoided. The recommended practice is to reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL, and then add glycerol (final concentration 50%) before aliquoting for long-term storage at -20°C/-80°C .
Recombinant UPF0316 protein SaurJH1_2001 is typically expressed in E. coli expression systems. The full-length protein (amino acids 1-200) is fused to an N-terminal His tag to facilitate purification. The His tag enables purification through metal affinity chromatography, typically using nickel or cobalt resins that selectively bind the polyhistidine sequence .
The purification process generally follows these steps:
Bacterial cell lysis to release the recombinant protein
Initial clarification of the lysate by centrifugation
Metal affinity chromatography using the His tag
Optional: Size exclusion chromatography for further purification
Quality control by SDS-PAGE to verify purity (>90%)
Lyophilization for stable storage
If problems with truncated products occur during expression, increasing the imidazole concentration during elution can help distinguish full-length proteins from truncated versions .
Quality control of recombinant UPF0316 protein SaurJH1_2001 typically involves multiple analytical techniques:
| Analytical Method | Purpose | Expected Result |
|---|---|---|
| SDS-PAGE | Assess purity and molecular weight | >90% purity, single band at expected MW |
| Western blot | Confirm identity using anti-His antibodies | Single specific band |
| Mass spectrometry | Verify exact molecular weight and sequence | Match to theoretical mass |
| Circular dichroism | Evaluate secondary structure | Consistent folding pattern |
| Dynamic light scattering | Detect aggregation | Monodisperse population |
| Endotoxin testing | Ensure safety for biological assays | <1 EU/mg protein |
For this specific protein, SDS-PAGE is the primary method reported to verify purity, with a standard of greater than 90% being acceptable for most research applications .
While the specific function of UPF0316 protein SaurJH1_2001 is not fully characterized, several approaches can be used to predict and investigate its role:
Sequence analysis suggests membrane association, indicating potential roles in:
Membrane transport or channel activity
Cell signaling
Cell wall integrity maintenance
Antibiotic resistance mechanisms
Host-pathogen interactions
Comparative genomics with related proteins in other bacterial species may provide functional clues. The UPF0316 family proteins are conserved across multiple bacterial species, suggesting an important biological role .
Gene expression analysis under different stress conditions could reveal patterns of upregulation or downregulation that correlate with specific cellular responses. For instance, examining expression during antibiotic exposure, nutrient limitation, or host interaction may provide functional insights .
To experimentally determine function, researchers should consider gene knockout studies followed by comprehensive phenotypic characterization, including growth rates, antibiotic susceptibility, and virulence in infection models.
Robust experimental design for studying UPF0316 protein SaurJH1_2001 function should incorporate the principles outlined by Fisher, focusing on manipulation of independent variables, appropriate controls, and careful measurement of dependent variables .
A comprehensive experimental approach might include:
| Experimental Approach | Key Design Elements | Expected Outcomes |
|---|---|---|
| Gene knockout studies | - CRISPR-Cas9 or allelic replacement - Multiple independent mutants - Complementation controls - Randomized blinded phenotypic assays | Phenotypic changes revealing physiological role |
| Protein localization | - Fluorescent protein fusion - Immunofluorescence microscopy - Subcellular fractionation - Controls for fixation artifacts | Cellular localization pattern |
| Interactome analysis | - Co-immunoprecipitation - Cross-linking mass spectrometry - Yeast two-hybrid screening - Negative controls | Protein interaction network |
| Structural studies | - X-ray crystallography - NMR spectroscopy - Cryo-EM - Molecular modeling | Three-dimensional structure revealing functional domains |
When designing these studies, researchers should employ the Solomon four-group design where appropriate to control for testing effects, especially in time-sensitive experiments . This design helps distinguish between the effects of pretesting, treatment, and their interaction by randomly assigning experimental units to four different groups.
While specific information about UPF0316 protein SaurJH1_2001's role in virulence is not directly available, we can contextualize potential contributions based on S. aureus pathogenesis.
S. aureus virulence depends on multiple factors including:
Adhesion proteins (like fibronectin-binding protein A and clumping factor A)
Toxins and enzymes
Immune evasion mechanisms
Biofilm formation
The UPF0316 protein's membrane association suggests potential involvement in one or more of these processes. For comparison, other S. aureus membrane proteins have established roles in virulence:
To investigate UPF0316 protein's role in virulence, researchers should:
Generate knockout mutants and test in infection models
Assess adhesion to relevant host cells
Examine immune response to the protein
Test for interactions with host proteins
Statistical analysis for UPF0316 protein research requires careful consideration of experimental design and data types. Based on statistical principles from experimental research, the following approaches are recommended :
For comparing multiple experimental conditions (e.g., different mutations or treatments):
ANOVA followed by appropriate post-hoc tests
Control for multiple comparisons using methods such as Bonferroni or Tukey's HSD
Include power analysis to determine adequate sample sizes
For time-series data (e.g., protein expression over time):
Repeated measures ANOVA for parametric data
Hazard function analysis for survival or failure time data
Time-series models for temporal dependencies
For protein-protein interaction studies:
Calculate correlation coefficients (Pearson's r for parametric data)
Spearman's rank correlation for non-parametric data
Analysis of concordant and discordant pairs for binary outcomes
For exploring complex datasets:
When analyzing protein function data, researchers should consider both statistical significance and biological significance, as statistically significant findings may not always translate to meaningful biological effects.
Understanding the interaction partners of UPF0316 protein SaurJH1_2001 is crucial for elucidating its function. Several complementary methods can be employed:
| Method | Technical Approach | Advantages | Limitations |
|---|---|---|---|
| Co-immunoprecipitation | Use anti-His antibodies to pull down UPF0316 and identify interacting proteins by mass spectrometry | Identifies physiologically relevant interactions | May miss weak or transient interactions |
| Bacterial two-hybrid | Express UPF0316 fused to DNA-binding domain and test against prey library | High-throughput screening | Potential false positives/negatives |
| Surface plasmon resonance | Immobilize UPF0316 on chip and measure binding kinetics of potential partners | Provides quantitative binding data | Requires purified interaction partners |
| Cross-linking mass spectrometry | Chemical cross-linking followed by MS/MS analysis | Identifies interaction interfaces | Complex data analysis |
| Proximity-dependent biotin labeling | Express UPF0316 fused to biotin ligase | Identifies proteins in close proximity in vivo | Requires genetic manipulation of S. aureus |
A successful example of protein interaction analysis in S. aureus is seen with the metastasis suppressor NME1 and dynamin (DNM2), where two-way co-immunoprecipitation confirmed their interaction, providing insights into their functional relationship .
For UPF0316 protein SaurJH1_2001, researchers should first identify potential interaction partners through large-scale methods like co-immunoprecipitation followed by mass spectrometry, then validate specific interactions using targeted approaches like surface plasmon resonance or ELISA.
Developing effective vaccines against S. aureus remains challenging due to the bacterium's complex pathogenesis and immune evasion mechanisms. To evaluate UPF0316 protein SaurJH1_2001 as a potential vaccine candidate, researchers should consider the following approaches:
Antigenicity assessment:
Analyze sequence conservation across S. aureus strains
Predict B-cell and T-cell epitopes using immunoinformatics
Test immunogenicity in animal models
Protective efficacy evaluation:
Measure antibody response (quantity and functionality)
Assess T-cell responses
Challenge immunized animals with S. aureus
Adjuvant optimization:
Test various adjuvant formulations
Evaluate different delivery systems
Measure impact on immune response quality
Previous S. aureus vaccine development efforts have encountered challenges, as seen with the capsular polysaccharide vaccine that showed modest efficacy (57-63%) that diminished over time . UPF0316 protein's potential as a vaccine candidate would need to be evaluated in light of these historical challenges.
A promising approach might be to include UPF0316 protein as part of a multi-component vaccine, targeting several virulence factors simultaneously to overcome the redundancy in S. aureus pathogenicity mechanisms .
Understanding the relationship between UPF0316 protein structure and function requires integrating multiple experimental and computational approaches:
Structural analysis methods:
X-ray crystallography for high-resolution static structure
NMR spectroscopy for solution structure and dynamics
Cryo-electron microscopy for larger assemblies
Circular dichroism for secondary structure content
Functional mapping approaches:
Site-directed mutagenesis of conserved residues
Deletion analysis of predicted domains
Chimeric protein construction
Chemical modifications of specific residues
Computational methods:
Homology modeling based on related structures
Molecular dynamics simulations
Protein-ligand docking
Evolutionary sequence analysis
A systematic approach would begin with in silico structure prediction and identification of conserved regions, followed by experimental validation through targeted mutagenesis. Functional assays would then be designed based on hypothesized roles, such as membrane transport, protein interaction, or enzymatic activity.
Exploratory data analysis (EDA) provides valuable insights before formal hypothesis testing. For UPF0316 protein research, EDA approaches can reveal patterns and generate hypotheses :
Data visualization techniques:
"Branch and leaf" plots for organizing clinical or experimental data
Heat maps for expression data across conditions
Network graphs for protein interaction data
Scatter plots for structure-function correlations
Descriptive statistics approaches:
Measures of central tendency and dispersion
Frequency distributions
Correlation analyses between variables
Contingency tables for categorical outcomes
Pattern recognition methods:
Cluster analysis to identify groups with similar characteristics
Principal component analysis to reduce dimensionality
Time series analysis for temporal patterns
Hazard function analysis for failure patterns
The qualitative behavior of the hazard function can reveal whether certain events (e.g., protein misfolding, aggregation, or activity loss) are increasing, decreasing, or constant over time . These informal procedures can provide important insights before formal statistical analysis.
Despite the available knowledge about UPF0316 protein SaurJH1_2001's sequence, expression, and handling, several critical questions remain unanswered:
What is the precise biological function of this protein in S. aureus?
Does it contribute to pathogenesis or antibiotic resistance?
What proteins does it interact with in vivo?
What is its three-dimensional structure?
Is it conserved across different S. aureus strains and isolates?
Could it serve as a therapeutic target or vaccine component?
Future research should prioritize these questions, using a combination of genetic, biochemical, structural, and immunological approaches. The integration of advanced techniques like CRISPR-Cas9 gene editing, cryo-electron microscopy, and systems biology approaches will be essential to fully characterize this protein.
Studying uncharacterized proteins presents unique challenges that require systematic approaches:
Develop multiple working hypotheses based on:
Sequence homology with characterized proteins
Genomic context and organization
Expression patterns under different conditions
Predicted structural features
Implement parallel experimental strategies:
Both forward and reverse genetic approaches
Complementary structural analysis methods
Multiple protein interaction detection systems
In vitro and in vivo functional assays
Utilize integrative data analysis:
Combine results from multiple experimental approaches
Apply machine learning to detect patterns in complex datasets
Develop computational models to generate testable predictions
Collaborate across disciplines to gain diverse perspectives